secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001558370-23-010301
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics stockholders elect all director nominees, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Three director nominees elected: Andrews (36.2M for, 0.5M withheld), Goldberg (32.6M/4.0M), Pearson (36.3M/0.4M); 14.2M broker non-votes.
- Ratification of Ernst & Young as auditor approved: 50.3M for, 0.5M against, 0.05M abstained.
- Advisory vote on executive compensation approved: 36.1M for, 0.4M against, 0.1M abstained; 14.2M broker non-votes.
- Approximately 79% of outstanding shares (50.9M of 64.2M) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837023010301/0001558370-23-010301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837023010301/glyc-20230519x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer